Literature DB >> 2121726

Purification and properties of multiple forms of dihydrodiol dehydrogenase from human liver.

A Hara1, H Taniguchi, T Nakayama, H Sawada.   

Abstract

Two acidic and three basic forms of monomeric dihydrodiol dehydrogenase with molecular weights in the range of 36,000-39,000 were purified from human liver. One acidic enzyme (pI 5.2), which was specific for NADP- and dihydrodiols of benzene and naphthalene, was immunologically identified as aldehyde reductase. The other four enzymes oxidized alicyclic alcohols as well as the dihydrodiols using both NADP+ and NAD+ as cofactors, but showed differences in specificity for hydroxysteroids and inhibitor sensitivity. Two of the basic enzymes (pI 9.7 and 9.1) exhibited a 20 alpha-hydroxysteroid dehydrogenase activity and sensitivity to 1,10-phenanthroline, whereas the third basic enzyme (pI 7.6) oxidized some 3 alpha-hydroxysteroids at low rates and was inhibited by cyclopentane-1,1-diacetic acid. Another acidic enzyme, which accounted for the largest amount of enzyme activity in the tissue and appeared in two heterogenous forms with pI values of 5.9 and 5.4, showed a high 3 alpha-hydroxysteroid dehydrogenase activity and was the most sensitive to inhibition by medroxyprogesterone acetate. The Km values of the enzymes, except the pI 5.2 enzyme, for hydroxysteroids (10(-6) to 10(-7) M) were lower than those for xenobiotic alcohols.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2121726     DOI: 10.1093/oxfordjournals.jbchem.a123189

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  16 in total

Review 1.  Aldo-keto reductases and formation of polycyclic aromatic hydrocarbon o-quinones.

Authors:  Trevor M Penning
Journal:  Methods Enzymol       Date:  2004       Impact factor: 1.600

2.  Reductive metabolism of nabumetone by human liver microsomal and cytosolic fractions: exploratory prediction using inhibitors and substrates as marker probes.

Authors:  Kaori Matsumoto; Tetsuya Hasegawa; Junichi Koyanagi; Tamiko Takahashi; Masayuki Akimoto; Kenji Sugibayashi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2015-06       Impact factor: 2.441

3.  Kinetic alteration of a human dihydrodiol/3alpha-hydroxysteroid dehydrogenase isoenzyme, AKR1C4, by replacement of histidine-216 with tyrosine or phenylalanine.

Authors:  T Ohta; S Ishikura; S Shintani; N Usami; A Hara
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

4.  Identification of amino acid residues responsible for differences in substrate specificity and inhibitor sensitivity between two human liver dihydrodiol dehydrogenase isoenzymes by site-directed mutagenesis.

Authors:  K Matsuura; Y Deyashiki; K Sato; N Ishida; G Miwa; A Hara
Journal:  Biochem J       Date:  1997-04-01       Impact factor: 3.857

5.  Molecular cloning, expression and catalytic activity of a human AKR7 member of the aldo-keto reductase superfamily: evidence that the major 2-carboxybenzaldehyde reductase from human liver is a homologue of rat aflatoxin B1-aldehyde reductase.

Authors:  L S Ireland; D J Harrison; G E Neal; J D Hayes
Journal:  Biochem J       Date:  1998-05-15       Impact factor: 3.857

6.  Structural and functional comparison of two human liver dihydrodiol dehydrogenases associated with 3 alpha-hydroxysteroid dehydrogenase activity.

Authors:  Y Deyashiki; H Taniguchi; T Amano; T Nakayama; A Hara; H Sawada
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

7.  Distribution and characterization of dihydrodiol dehydrogenases in mammalian ocular tissues.

Authors:  A Hara; T Nakayama; T Harada; T Kanazu; M Shinoda; Y Deyashiki; H Sawada
Journal:  Biochem J       Date:  1991-04-01       Impact factor: 3.857

8.  Sequence of the cDNA of a human dihydrodiol dehydrogenase isoform (AKR1C2) and tissue distribution of its mRNA.

Authors:  H Shiraishi; S Ishikura; K Matsuura; Y Deyashiki; M Ninomiya; S Sakai; A Hara
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

9.  Roles of the C-terminal domains of human dihydrodiol dehydrogenase isoforms in the binding of substrates and modulators: probing with chimaeric enzymes.

Authors:  K Matsuura; A Hara; Y Deyashiki; H Iwasa; T Kume; S Ishikura; H Shiraishi; Y Katagiri
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

10.  Molecular cloning of two human liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase isoenzymes that are identical with chlordecone reductase and bile-acid binder.

Authors:  Y Deyashiki; A Ogasawara; T Nakayama; M Nakanishi; Y Miyabe; K Sato; A Hara
Journal:  Biochem J       Date:  1994-04-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.